Veristat is a problem-solving brand that partners with clients to deliver life-changing therapies. With 29 years of experience in clinical trial planning and execution, their scientific experts and regulatory upholders tackle the unique challenges of accelerating therapies through development and regulatory approval. Veristat has proudly supported the successful approval of numerous therapies, including the first gene therapy approved in Europe.

As your partner, Veristat offers flexible engagement models and development plans built for success. They provide support throughout the entire clinical development process, from study start to commercialization, and offer specialized services to advance therapies into clinical development, regulatory approval, and post-marketing. Whether you're an emerging, small, or mid-size biopharma company, Veristat's well-constructed strategies and expertise ensure positive results and sustained commercial success.

Their dedicated teams are passionate about guiding clients through successful clinical trials and regulatory submissions, making a difference every day. With their growth and strategic investments, Veristat is ready to make the impossible possible for your therapy